Second WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, 6-7 December 2005, WHO HQ Geneva
Approaches to cross-reacting and long duration immunity (1)
Sub session on development of M2 vaccine
-
M2-specific protection in the mouse model - Walter Gerhard
pdf, 132kb -
Influenza epitope vaccine based on M2 protein - Wanli Liu
pdf, 1.56Mb -
Preclinical evaluation of M2 vaccine in animals - Xiaoping Liang
pdf, 174kb -
Preclinical development of a universal influenza - Xavier Saelens
pdf, 534kb -
A vaccine based on the extracellular domain of M2 - Ashley Birkett
pdf, 756kb -
M2 based influenza vaccine. Weak protection mediated via antibody-dependent NK cell activity - Martin Bachmann
pdf, 1.36Mb